STOCK TITAN

Aemetis Stock Price, News & Analysis

AMTX Nasdaq

Welcome to our dedicated page for Aemetis news (Ticker: AMTX), a resource for investors and traders seeking the latest updates and insights on Aemetis stock.

Aemetis, Inc. (NASDAQ: AMTX) generates frequent news as a renewable natural gas, renewable fuel, and biochemicals company with operations in California and India. Company press releases and third-party coverage focus on developments across its dairy renewable natural gas platform, California ethanol plant, and India biodiesel facility, as well as its participation in state and federal clean fuel programs.

News about Aemetis often highlights progress in its dairy biogas digester network and RNG pipeline system, including the number of operating digesters, production volumes, and approvals of California Low Carbon Fuel Standard (LCFS) pathways. Updates also cover revenue contributions from RNG, D3 RINs, and the monetization of Section 45Z Clean Fuel Production Credits and Section 48 or 48C investment tax credits.

Another recurring theme in Aemetis news is the performance and upgrades at its 65 million gallon per year ethanol plant in Keyes, California. Articles describe carbon intensity reduction initiatives, such as the Mechanical Vapor Recompression (MVR) project, grants and tax credits supporting the project, and the plant’s role in supplying animal feed to dairies in the California Central Valley.

Coverage also addresses Aemetis’ India biodiesel operations, including biodiesel sales to India Oil Marketing Companies and refined glycerin production for customers in India and Europe. Financial result announcements summarize quarterly revenues, segment performance, operating losses, and capital investments in projects like dairy digesters and ethanol carbon intensity reduction.

Investors and observers who follow AMTX news can track regulatory developments affecting ethanol blends, LCFS and federal tax credit programs, as well as updates on Aemetis’ planned sustainable aviation fuel, renewable diesel, and carbon sequestration projects. The news flow provides context on how policy changes, project milestones, and financing arrangements influence the company’s renewable fuels and RNG business.

Rhea-AI Summary

Aemetis, Inc. (NASDAQ: AMTX) has completed the construction of its first two dairy digesters and a four-mile pipeline for producing Renewable Natural Gas (RNG). This project aims to supply below-zero carbon intensity RNG, replacing petroleum-based natural gas at its Keyes ethanol facility and fueling RNG trucks and buses. The company is also advancing its Central Dairy Digester Project with plans for additional dairy partnerships and pipeline installations. These initiatives are expected to enhance revenue and reduce carbon intensity while supporting the conversion of methane from dairy waste into sustainable energy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-23.84%
Tags
-
Rhea-AI Summary

Aemetis announced on August 18, 2020, that it has regained compliance with NASDAQ Listing Rules. The company received confirmation from NASDAQ that it has maintained a minimum market value of publicly held shares of $15 million and a closing bid price of at least $1.00 per share for 10 consecutive trading days. This compliance determination resolves prior concerns regarding its listing status. Aemetis specializes in advanced renewable fuels and biochemicals, operating facilities in California and India, and is engaged in innovative projects aimed at producing sustainable energy alternatives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.68%
Tags
none
-
Rhea-AI Summary

Aemetis, Inc. (NASDAQ:AMTX) reported second-quarter 2020 earnings of $0.10 per share and net income of $2.2 million, significantly improving from a net loss of $13.9 million in Q2 2019. Revenues reached $47.8 million, driven by high-grade alcohol sales for hand sanitizers, despite a decline from $50.6 million in the previous year. Gross profit rose to $14.1 million from $3.3 million YoY. Adjusted EBITDA increased to $11.2 million. Aemetis is expanding its production to include USP-grade alcohol by Q1 2021, anticipating continued market growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.47%
Tags
Rhea-AI Summary

Aemetis, Inc. (NASDAQ:AMTX) reported a net income of $2.2 million and earnings of $0.10 per share for Q2 2020, driven by a surge in high-grade alcohol sales for hand sanitizer due to COVID-19. Revenues for the quarter were $47.8 million, slightly down from $50.6 million in Q2 2019. Gross profit increased significantly to $14.1 million from $3.3 million year-over-year. Aemetis plans to produce USP grade alcohol by Q1 2021 and is expanding its marketing channels for sanitizer products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.47%
Tags
-
Rhea-AI Summary

Aemetis launched its new subsidiary, Aemetis Health Products, focused on producing and marketing blended liquid and gel hand sanitizers as both bulk and packaged products. The company has become the largest producer of high-grade sanitizer alcohol in the western U.S. due to increased demand during the COVID-19 pandemic. Aemetis is also upgrading its plant to manufacture USP medical grade alcohol in Keyes, California. This initiative reflects the company's strategic expansion into sanitizer markets while enhancing its existing product offerings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.52%
Tags
none
-
Rhea-AI Summary

Aemetis, Inc. (NASDAQ: AMTX) will hold a conference call on May 14, 2020, at 11 am PST to discuss its Q1 2020 earnings report. Participants can join via toll-free numbers or an international line. The call will include a Q&A segment, allowing attendees to submit questions. A recording of the call will be available until May 21, 2020, through designated phone lines. Aemetis focuses on renewable fuels and biochemicals, operating an ethanol production facility in California and a biodiesel plant in India, while developing projects for Renewable Natural Gas.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.87%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
46.55%
Tags
none

FAQ

What is the current stock price of Aemetis (AMTX)?

The current stock price of Aemetis (AMTX) is $2.29 as of April 10, 2026.

What is the market cap of Aemetis (AMTX)?

The market cap of Aemetis (AMTX) is approximately 163.5M.